Rainbow Seed Fund News

Chemical detection innovator secures access to global markets Early-stage investor Rainbow Seed Fund today announces that Oxfordshire-based Cobalt, a provider of highly differentiated Raman spectroscopic instruments, has been acquired by Agilent Technologies Inc. Cobalt, a spin-out from the UK’s Science and Technology Facilities Council (STFC) Rutherford Appleton Laboratory which was funded from the earliest stages […]

read more

  Quethera, a biopharmaceutical company developing therapies for ocular disorders, today presented strong efficacy data at the 2017 Association for Research in Vision and Ophthalmology (ARVO) conference showing its gene therapy QTA020V resulted in a 61% reduction in retinal ganglion cell (RGC) loss in a widely used experimental model of glaucoma. In addition, the company […]

read more

  May 03, 2017 Justin Petrone www.genomeweb.com British molecular diagnostics company Cytox plans to make a molecular test for the early-stage diagnosis of Alzheimer’s disease available in the US by year end. The Oxford-based firm is also in discussions with multiple pharmaceutical and biotechnology companies that wish to use its test, which is run on […]

read more

1 2 3 9